Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
buprenorphine (1 trial)
dasabuvir (Exviera) (1 trial)
naloxone (narcan) (1 trial)
ombitasvir (Viekira Pak) (1 trial)
paritaprevir (viekira pak) (1 trial)
promethazine hydrochloride (phenergan) (1 trial)
ribavirin (virazole) (1 trial)
ritonavir (Norvir) (1 trial)
saroglitazar (1 trial)
Hepatic Encephalopathy (Phase 4)
Hepatic Insufficiency (Phase 4)
Hepatitis (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Liver Failure (Phase 4)
Renal Insufficiency (Phase 1)
Trials (3 total)
Trial APIs (9 total)